ProKidney Corp.
PROK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $217 | $221 | $230 | $76 |
| % Growth | -1.8% | -3.9% | 202.6% | – |
| Cost of Goods Sold | $1,398 | $0 | $0 | $0 |
| Gross Profit | -$1,181 | $221 | $230 | $76 |
| % Margin | -544.2% | 100% | 100% | 100% |
| R&D Expenses | $26,821 | $25,882 | $27,263 | $39,781 |
| G&A Expenses | $0 | $14,048 | $14,355 | $11,866 |
| SG&A Expenses | $10,537 | $14,048 | $14,355 | $11,866 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $37,358 | $39,930 | $41,618 | $51,647 |
| Operating Income | -$38,539 | -$39,709 | -$41,388 | -$51,571 |
| % Margin | -17,759.9% | -17,967.9% | -17,994.8% | -67,856.6% |
| Other Income/Exp. Net | $3,256 | $3,592 | $4,027 | $4,790 |
| Pre-Tax Income | -$35,283 | -$36,117 | -$37,361 | -$46,781 |
| Tax Expense | $560 | $848 | $591 | $1,702 |
| Net Income | -$16,469 | -$16,552 | -$16,734 | -$21,278 |
| % Margin | -7,589.4% | -7,489.6% | -7,275.7% | -27,997.4% |
| EPS | -0.12 | -0.13 | -0.13 | -0.17 |
| % Growth | 7.7% | 0% | 23.5% | – |
| EPS Diluted | -0.12 | -0.13 | -0.13 | -0.17 |
| Weighted Avg Shares Out | 134,993 | 130,731 | 128,976 | 128,054 |
| Weighted Avg Shares Out Dil | 134,993 | 130,731 | 128,976 | 128,054 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,258 | $3,593 | $4,027 | $4,792 |
| Interest Expense | $2 | $1 | $0 | $2 |
| Depreciation & Amortization | $1,398 | $1,465 | $1,600 | $1,574 |
| EBITDA | -$33,883 | -$34,651 | -$35,761 | -$45,205 |
| % Margin | -15,614.3% | -15,679.2% | -15,548.3% | -59,480.3% |